News

Fall edition Venture Challenge now open for applications

As of this week, enterprising researchers can submit their candidacy for the Fall edition of the Venture Challenge, which NWO organises on behalf of the Ministry of Economic Affairs and Climate.
Fall edition Venture Challenge now open for applications

Venture Challenge alumnus Core Life Analytics Closes €1M Series A Deal

The Netherlands-based data analytics company, Core Life Analytics, has closed a €1m Series A financing round. The investor team is composed of BOM Brabant Ventures, Utrecht Holdings and TechFund One.
Venture Challenge alumnus Core Life Analytics Closes €1M Series A Deal

Novalis Biotech Incubation to invest in LS@W alumnus Cergentis

Novalis Biotech Incubation, a Belgian venture capital investment fund, is investing seed capital in Cergentis for an undisclosed amount.
Novalis Biotech Incubation to invest in LS@W alumnus Cergentis

Spring edition Venture Challenge starts in the summer

Six innovative teams were selected this spring to participate in the Venture Challenge, a coaching programme for start-ups in the Life Sciences & Health that is being organised for the first time under the auspices of
Spring edition Venture Challenge starts in the summer

Venture Challenge alumnus Predica Diagnostics is supported by the RedMedtech Discovery Fund

May 8, 2020 RedMedTech Discovery Fund supports CervicaDx development
Venture Challenge alumnus Predica Diagnostics is supported by the RedMedtech Discovery Fund

Corona bridging loan for startups, scale-ups likely available from end of April

Last Tuesday, April 7, the Dutch cabinet announced that it will initially make € 100 million available for bridging loans to start-ups, scale-ups and innovative SMEs that have been financially affected by the impact of the corona crisis.
Corona bridging loan for startups, scale-ups likely available from end of April

Venture Challenge Alumnus AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)

Today we are reminded that antibiotics are an important part of treatment regiments not only for severe antiviral infections, such as COVID-19, but also other hospitalized patients with multidrug-resistant (MDR) secondary infections
Venture Challenge Alumnus AGILeBiotics contributes to fight against future pandemic infections (e.g. COVID-19)

AGILeBiotics appoints new CEO Victor Schut

Victor Schut has been appointed as the new Chief Executive Officer (CEO) of AGILeBiotics and co-founder Dr. Andreas A. Bastian has now taken on the role of Chief Operating Officer (COO).
AGILeBiotics appoints new CEO Victor Schut

Six teams selected for the Venture Challenge Spring 2020 - Workshops postponed due to COVID-19 restrictions

Six teams have been selected by NWO for participation in the Venture Challenge Spring 2020 edition.
Six teams selected for the Venture Challenge Spring 2020 - Workshops postponed due to COVID-19 restrictions